HCC recurrence in liver transplants treated with hypothermic oxygenated machine perfusion: An international matched cohort study

Background & Aims: Liver transplantation (LT) for hepatocellular carcinoma (HCC) is performed worldwide, with 5-year survival rates of approximately 70%. However, post-transplant HCC recurrence occurs in 15-20% of recipients. We aimed to evaluate, for the first time, long-term recurrence-free su...

Descrición completa

Detalles Bibliográficos

Principais autores:	Janina Eden, Philip C. Müller, Christoph Kuemmerli, Marco Bongini, Francesca Albanesi, Carlo Sposito, Gabriela Berlakovich, Bettina M. Buchholz, Florin Botea, Stefania Camagni, Matteo Cescon, Umberto Cillo, Fabio Colli, Philippe Compagnon, Luciano G. De Carlis, Riccardo De Carlis, Fabrizio Di Benedetto, Jule Dingfelder, Dulce Diogo, Daniele Dondossola, Moritz Drefs, Jiri Fronek, Giuliana Germinario, Enrico Gringeri, Christiano Guidetti, Georg Györi, Matej Kocik, Efrayim H. Küçükerbil, Dionysios Koliogiannis, Hwai-Ding Lam, Georg Lurje, Paolo Magistri, Diethard Monbaliu, Mostafa el Moumni, Beat P. Müller, Damiano Patrono, Wojciech G. Polak, Robert J. Porte, Matteo Ravaioli, Michel Rayar, Renato Romagnoli, Gustaf Sörensen, Deniz Uluk, Pierre A. Clavien, Vincenzo Mazzaferro, Philipp Dutkowski, Vincent E. de Meijer
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2026-03-01
Series:	JHEP Reports
Assuntos:	Hepatocellular carcinoma HCC recurrence liver transplantation hypothermic oxygenated machine perfusion HOPE ischemia reperfusion injury
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2589555926000029
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!